跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,791 条关于
“ERK1/2 MAPK”
全部
65,791
临床试验
43,003
药物
7,380
机构
1,400
资讯
14,008
去年
Pegmolesatide Shows Promise as Long-Acting Anemia Treatment in Phase II Trials for CKD Patients
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
去年
Mosaic Therapeutics Acquires Two Clinical-Stage Oncology Programs from Astex to Develop Novel Combination Therapies
8个月前
Derazantinib Enhances Gemcitabine Efficacy in Pancreatic Cancer by Suppressing NF-κB and MAPK Pathways
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
2年前
Nested Therapeutics' NST-628: A Novel Pan-RAF–MEK Molecular Glue for MAPK Pathway Inhibition
去年
Abemaciclib Shows Promise in Meningioma, Disappoints in Glioblastoma Combination
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
去年
FORE Biotherapeutics Reports Durable Clinical Benefit with Plixorafenib in BRAF-Altered Thyroid Cancers
去年
Rapamycin Shows Promise in Periodontitis and Oral Cancer Treatment
第 1 页,共 1401 页
上一页
下一页